Form 4: Teladoc Health Executive Trades TDOC Shares
Statement of Changes in Beneficial Ownership
Carlos Nueno, President of International at Teladoc Health, reported transactions involving restricted stock units and common stock.
Summary
- Carlos Nueno, President of International at Teladoc Health, Inc. (TDOC), engaged in several transactions on June 1st and June 2nd, 2026.
- On June 1, 2026, Nueno acquired 4,556 shares of common stock through the conversion of restricted stock units (RSUs) and an additional 8,716 shares via RSUs.
- Also on June 1, 2026, Nueno acquired 4,556 shares and 8,716 shares through RSUs, increasing his total beneficial ownership.
- On June 2, 2026, Nueno disposed of 6,196 shares of common stock at a price of $7.627 per share.
- These disposed shares were used to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Nueno beneficially owns 57,671 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions related to executive compensation rather than significant strategic shifts or performance indicators.
Positives
- Acquisition of shares through RSU conversion indicates continued vesting and potential alignment with company performance.
- The reporting person, Carlos Nueno, holds a significant number of shares (57,671) after the reported transactions, suggesting a substantial personal investment in the company.
Negatives
- Disposal of shares to cover tax withholding obligations, while standard, represents a reduction in direct beneficial ownership.
- The sale price of $7.627 per share on June 2, 2026, may be lower than the purchase price or grant value of the RSUs, depending on the grant dates and terms.
Risks
- The disposal of shares to cover tax obligations could be interpreted as a need for liquidity by the executive, though this is a common practice.
- The relatively low sale price of $7.627 per share might reflect a depressed stock price at the time of the transaction, indicating potential market concerns.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports past transactions.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those involving the disposal of shares to cover taxes, are common for executives. However, the volume and timing of such transactions can sometimes be interpreted by the market as signals regarding the executive's confidence in the company's future stock performance.
Stakeholder Impact
- Shareholders: The disposal of shares by an executive could be perceived negatively if interpreted as a lack of confidence, though it is a standard tax-related event.
- Employees: The vesting of RSUs for executives can be seen as a reward for performance and a retention tool, aligning executive interests with the company's success.
- Management: The transactions reflect the standard compensation and tax management practices for senior executives.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Grant date for 54,675 restricted stock units to Carlos Nueno. |
| 03/01/2025 | Grant date for 104,602 restricted stock units to Carlos Nueno. |
| 06/01/2025 | Start date for quarterly vesting of a portion of RSUs granted on March 19, 2024. |
| 06/01/2026 | Transaction date for acquisition of common stock via RSU conversion and vesting. |
| 06/02/2026 | Transaction date for disposal of common stock to cover tax withholding. |
| 06/03/2026 | Date of filing for the Form 4 statement. |
Keywords
Teladoc Health, TDOC, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU Vesting, Carlos Nueno, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.